Cardiovascular benefits associated with some GLP-1 receptor agonists (semaglutide, dulaglutide, liraglutide) observed in clinical trials are likely to diminish after discontinuation, though the exact persistence of these benefits remains uncertain
With more people staying on therapy longer, new indications on the rise and a strong pipeline ahead, employers need to take a sharper, more strategic approach to managing this drug class, she said
Skin brightening with glutathione is not permanent
Amanda Olsen, PA-C, delivers skin rejuvenation and GLP-ReplaceAddressLinkions at our practice
The most common side effect across all GLP-1 medications is gastrointestinal discomfort, particularly nausea
Lin and A.B